CompanyDrug

CStone’s PD-L1 Inhibitor Sugemalimab Accepted for Review in Gastric Cancer

Company

Immorna Closes Series A+ and A++ Rounds Near $100M for mRNA Development

CompanyDrug

Sanofi’s VaxigripTetra Approved for Pediatric Influenza Vaccination in China

CompanyDrug

Enhertu Approved in China for HER2-Positive Breast Cancer

CompanyDrug

Novartis’ Revolade Approved for Severe Aplastic Anemia in China

CompanyDeals

Kelun-Biotech Files for Hong Kong IPO with Goldman Sachs and CITIC Securities

CompanyDrug

Accutar Biotech Begins Phase I Trial for AC0176 in China

CompanyDrug

BeiGene’s Tislelizumab Approved for Gastric Tumors in China

CompanyDeals

SciClone Partners with Cowell Health to Enhance Cancer Treatment Accessibility

CompanyDeals

Baheal Pharmaceutical Partners with Novartis for Votrient Commercialization

CompanyDrug

Grand Pharma’s First-in-Class RDC ITM-11 Accepted for IND Review

CompanyDeals

Jacobio Pharma Partners with WestChina-Frontier for Preclinical Safety Studies